Stocks and Investing Stocks and Investing
Fri, December 22, 2023

Mara Goldstein Initiated (SNDX) at Strong Buy and Held Target at $45 on, Dec 22nd, 2023


Published on 2024-10-28 08:06:54 - WOPRAI, Mara Goldstein
  Print publication without navigation


Mara Goldstein of Mizuho, Initiated "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy and Held Target at $45 on, Dec 22nd, 2023.

Mara has made no other calls on SNDX in the last 4 months.



There are 5 other peers that have a rating on SNDX. Out of the 5 peers that are also analyzing SNDX, 0 agree with Mara's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Mara


  • Bradley Canino of "Stifel" Maintained at Strong Buy with Decreased Target to $36 on, Thursday, October 26th, 2023
  • Jason Zemansky of "B of A Securities" Initiated at Strong Buy and Held Target at $29 on, Wednesday, October 25th, 2023
  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $38 on, Tuesday, October 17th, 2023
  • Chris Shibutani of "Goldman Sachs" Initiated at Strong Buy and Held Target at $30 on, Wednesday, October 11th, 2023
  • Joel Beatty of "Baird" Maintained at Buy with Decreased Target to $28 on, Tuesday, October 3rd, 2023
Contributing Sources